These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19496316)

  • 1. Is the current dose of a conventional oxytetracycline formulation adequate for the management of infections in sheep?
    Snyman MG; Naidoo V; de Bruin C; Swan GE
    J S Afr Vet Assoc; 2008 Dec; 79(4):171-4. PubMed ID: 19496316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial susceptibility of Mycoplasma mycoides mycoides large colony and Arcanobacterium pyogenes isolated from clinical cases of ulcerative balanitis and vulvitis in Dorper sheep in South Africa.
    Kidanemariam A; Gouws J; van Vuuren M; Gummow B
    J S Afr Vet Assoc; 2005 Dec; 76(4):204-8. PubMed ID: 16642716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of marbofloxacin in loggerhead sea turtles (Caretta caretta) after single intravenous and intramuscular doses.
    Lai OR; Marín P; Laricchiuta P; Marzano G; Crescenzo G; Escudero E
    J Zoo Wildl Med; 2009 Sep; 40(3):501-7. PubMed ID: 19746866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Potter T; Pelligand L; Toutain PL
    J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline administered alone and in combination with carprofen in calves.
    Brentnall C; Cheng Z; McKellar QA; Lees P
    Res Vet Sci; 2013 Jun; 94(3):687-94. PubMed ID: 23415880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of oxytetracycline administered alone and in combination with carprofen in calves.
    Brentnall C; Cheng Z; McKellar QA; Lees P
    Vet Rec; 2012 Sep; 171(11):273. PubMed ID: 22843613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    El Korchi G; Prats C; Arboix M; Pérez B
    J Vet Pharmacol Ther; 2001 Aug; 24(4):247-50. PubMed ID: 11555179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic behavior of doxycycline after intramuscular injection in sheep.
    Castro Robles LJ; Sahagún Prieto AM; Diez Liébana MJ; Fernández Martínez N; Sierra Vega M; García Vieitez JJ
    Am J Vet Res; 2012 May; 73(5):714-8. PubMed ID: 22533405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial culture and antibiotic susceptibility testing.
    Pierce-Hendry SA; Dennis J
    Compend Contin Educ Vet; 2010 Jul; 32(7):E1-5; quiz E6. PubMed ID: 20957608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The implementation of the broth microdilution method to determine bacterial susceptibility to antimicrobial agents].
    Rocksin A; Gerlach GF; Schwarz S
    Berl Munch Tierarztl Wochenschr; 2007; 120(1-2):42-9. PubMed ID: 17290942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oxytetracycline after intravenous administration at two dose levels to hens.
    Moreno L; Serrano JM; Reja A; Guimera E; Escudero E
    J Vet Pharmacol Ther; 1996 Dec; 19(6):495-7. PubMed ID: 8971681
    [No Abstract]   [Full Text] [Related]  

  • 14. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of oxytetracycline and penicillin G in tammar wallabies (Macropus eugenii).
    McLelland DJ; Barker IK; Crawshaw G; Hinds LA; Spilsbury L; Johnson R
    J Vet Pharmacol Ther; 2011 Apr; 34(2):160-7. PubMed ID: 21395607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Short- and Long-acting Formulations of Oxytetracycline After Intramuscular Administration in Chickens.
    Gberindyer AF; Okpeh ER; Semaka AA
    J Avian Med Surg; 2015 Dec; 29(4):298-302. PubMed ID: 26771319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of a long-acting formulation of oxytetracycline in sheep and goats.
    Escudero E; Carceles CM; Ponferrada C; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):75-7. PubMed ID: 8992031
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro susceptibilities of field isolates of Mycoplasma agalactiae.
    Antunes NT; Tavío MM; Assunção P; Rosales RS; Poveda C; de la Fé C; Gil MC; Poveda JB
    Vet J; 2008 Sep; 177(3):436-8. PubMed ID: 17604191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
    Banting AL; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
    Strukova EN; Portnoy YA; Zinner SH; Firsov AA
    J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.